Henrik N. Kløverpris

researcher

Henrik N. Kløverpris is …
instance of (P31):
humanQ5

External links are
P2798Loop ID269660
P496ORCID iD0000-0002-2165-3313
P1153Scopus author ID16230399500

P108employerUniversity of OxfordQ34433
University of CopenhagenQ186285
University College LondonQ193196
University of KwaZulu-NatalQ727516
P735given nameHenrikQ594279
HenrikQ594279
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q35141000A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape
Q34998830A randomised, placebo-controlled, first-in-human study of a novel clade C therapeutic peptide vaccine administered ex vivo to autologous white blood cells in HIV infected individuals
Q35613273CD8+ TCR Bias and Immunodominance in HIV-1 Infection
Q42275339CD8αα Expression Marks Terminally Differentiated Human CD8+ T Cells Expanded in Chronic Viral Infection.
Q64229951Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children
Q36397593Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope
Q37714013Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints
Q36607025Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells
Q28748976Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells
Q36363448HIV control through a single nucleotide on the HLA-B locus
Q33566546HIV subtype influences HLA-B*07:02-associated HIV disease outcome
Q37081581HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703
Q35665876HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control
Q37252948HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01
Q39631406HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides
Q34833986High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.
Q58746597High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not Adults
Q52812457Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency.
Q24289630Human T cell responses to Japanese encephalitis virus in health and disease
Q35577267Human and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of TCR Selection
Q40140237Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope.
Q40191772Identification of an HLA-A*0201 restricted Bcl2-derived epitope expressed on tumors.
Q44952607Identification of conserved subdominant HIV Type 1 CD8(+) T Cell epitopes restricted within common HLA Supertypes for therapeutic HIV Type 1 vaccines
Q47099267Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations.
Q64252443Increased Regulatory T-Cell Activity and Enhanced T-Cell Homeostatic Signaling in Slow Progressing HIV-infected Children
Q57916541Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes
Q40019073Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression.
Q36074846Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point
Q59335092Major TCR Repertoire Perturbation by Immunodominant HLA-B44:03-Restricted CMV-Specific T Cells
Q39278519Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy
Q34984237Nef-specific CD8+ T cell responses contribute to HIV-1 immune control
Q37215858Non-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individuals
Q37252903Nonhuman TRIM5 Variants Enhance Recognition of HIV-1-Infected Cells by CD8+ T Cells.
Q39278529Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection
Q34197037Programmed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load
Q26772713Role of HLA Adaptation in HIV Evolution
Q44216622Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.
Q43681799Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals
Q61807031Type 3 ILCs in Lung Disease

Search more.